Response to ‘Growing evidence supports low-dose ketamine infusions to facilitate opioid tapering’

First of all, we would like to thank Mukhdomi and colleagues for their letter1 regarding our article entitled ‘Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid use disorder: a historical cohort study’.2